ESR1 and breast cancer: Our laboratory has demonstrated that activation of the p53 pathway in ERα-positive breast cancer cells rapidly, within hours, shuts down DNA replication, downregulates proteins involved in apoptosis, and increases the levels of proteins that are involved in normal breast cell metabolism [90,97,98].